Annual EBITDA
-$66.30 M
-$193.01 M-152.32%
31 December 2023
Summary:
Molecular Partners AG annual earnings before interest, taxes, depreciation & amortization is currently -$66.30 million, with the most recent change of -$193.01 million (-152.32%) on 31 December 2023. During the last 3 years, it has fallen by -$2.73 million (-4.30%). MOLN annual EBITDA is now -152.32% below its all-time high of $126.71 million, reached on 31 December 2022.MOLN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$18.28 M
-$2.28 M-14.22%
01 September 2024
Summary:
Molecular Partners AG quarterly earnings before interest, taxes, depreciation & amortization is currently -$18.28 million, with the most recent change of -$2.28 million (-14.22%) on 01 September 2024. Over the past year, it has dropped by -$6.02 million (-49.10%). MOLN quarterly EBITDA is now -110.96% below its all-time high of $166.72 million, reached on 31 March 2022.MOLN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$68.17 M
-$6.02 M-9.69%
01 September 2024
Summary:
Molecular Partners AG TTM earnings before interest, taxes, depreciation & amortization is currently -$68.17 million, with the most recent change of -$6.02 million (-9.69%) on 01 September 2024. Over the past year, it has dropped by -$6.03 million (-9.71%). MOLN TTM EBITDA is now -151.52% below its all-time high of $132.33 million, reached on 31 December 2022.MOLN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MOLN EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -152.3% | -49.1% | -9.7% |
| 3 y3 years | -4.3% | -45.2% | +3.4% |
| 5 y5 years | -79.6% | - | - |
MOLN EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -152.3% | +0.1% | -111.0% | +15.5% | -151.5% | +3.4% |
| 5 y | 5 years | -152.3% | +0.1% | -111.0% | +19.7% | -151.5% | +9.2% |
| alltime | all time | -152.3% | +0.1% | -111.0% | +19.7% | -151.5% | +9.2% |
Molecular Partners AG EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$18.28 M(+14.2%) | -$68.17 M(+9.7%) |
| June 2024 | - | -$16.00 M(+30.6%) | -$62.15 M(-1.7%) |
| Mar 2024 | - | -$12.26 M(-43.3%) | -$63.25 M(-4.6%) |
| Dec 2023 | -$66.30 M(-152.3%) | -$21.63 M(+76.4%) | -$66.28 M(+6.7%) |
| Sept 2023 | - | -$12.26 M(-28.3%) | -$62.14 M(-1.3%) |
| June 2023 | - | -$17.10 M(+11.9%) | -$62.95 M(+26.7%) |
| Mar 2023 | - | -$15.29 M(-12.6%) | -$49.68 M(-137.5%) |
| Dec 2022 | $126.71 M(-290.9%) | -$17.48 M(+33.7%) | $132.33 M(+0.9%) |
| Sept 2022 | - | -$13.07 M(+240.8%) | $131.18 M(-0.4%) |
| June 2022 | - | -$3.84 M(-102.3%) | $131.67 M(+11.9%) |
| Mar 2022 | - | $166.72 M(-994.7%) | $117.70 M(-277.2%) |
| Dec 2021 | -$66.38 M | -$18.63 M(+48.0%) | -$66.41 M(-5.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$12.59 M(-29.3%) | -$70.55 M(-6.0%) |
| June 2021 | - | -$17.81 M(+2.5%) | -$75.05 M(+31.1%) |
| Mar 2021 | - | -$17.38 M(-23.7%) | -$57.25 M(+43.6%) |
| Dec 2020 | -$63.56 M(+87.3%) | -$22.78 M(+33.2%) | -$39.87 M(+133.2%) |
| Sept 2020 | - | -$17.09 M | -$17.09 M |
| Dec 2019 | -$33.93 M(-8.1%) | - | - |
| Dec 2018 | -$36.92 M(+47.2%) | - | - |
| Dec 2017 | -$25.07 M(+41.7%) | - | - |
| Dec 2016 | -$17.70 M(-1963.3%) | - | - |
| Dec 2015 | $949.80 K(-159.0%) | - | - |
| Dec 2014 | -$1.61 M(-118.8%) | - | - |
| Dec 2013 | $8.56 M | - | - |
FAQ
- What is Molecular Partners AG annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Molecular Partners AG?
- What is Molecular Partners AG annual EBITDA year-on-year change?
- What is Molecular Partners AG quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Molecular Partners AG?
- What is Molecular Partners AG quarterly EBITDA year-on-year change?
- What is Molecular Partners AG TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Molecular Partners AG?
- What is Molecular Partners AG TTM EBITDA year-on-year change?
What is Molecular Partners AG annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of MOLN is -$66.30 M
What is the all time high annual EBITDA for Molecular Partners AG?
Molecular Partners AG all-time high annual earnings before interest, taxes, depreciation & amortization is $126.71 M
What is Molecular Partners AG annual EBITDA year-on-year change?
Over the past year, MOLN annual earnings before interest, taxes, depreciation & amortization has changed by -$193.01 M (-152.32%)
What is Molecular Partners AG quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of MOLN is -$18.28 M
What is the all time high quarterly EBITDA for Molecular Partners AG?
Molecular Partners AG all-time high quarterly earnings before interest, taxes, depreciation & amortization is $166.72 M
What is Molecular Partners AG quarterly EBITDA year-on-year change?
Over the past year, MOLN quarterly earnings before interest, taxes, depreciation & amortization has changed by -$6.02 M (-49.10%)
What is Molecular Partners AG TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of MOLN is -$68.17 M
What is the all time high TTM EBITDA for Molecular Partners AG?
Molecular Partners AG all-time high TTM earnings before interest, taxes, depreciation & amortization is $132.33 M
What is Molecular Partners AG TTM EBITDA year-on-year change?
Over the past year, MOLN TTM earnings before interest, taxes, depreciation & amortization has changed by -$6.03 M (-9.71%)